BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20179752)

  • 1. DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
    Houshdaran S; Hawley S; Palmer C; Campan M; Olsen MN; Ventura AP; Knudsen BS; Drescher CW; Urban ND; Brown PO; Laird PW
    PLoS One; 2010 Feb; 5(2):e9359. PubMed ID: 20179752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
    Dai W; Teodoridis JM; Zeller C; Graham J; Hersey J; Flanagan JM; Stronach E; Millan DW; Siddiqui N; Paul J; Brown R
    Clin Cancer Res; 2011 Jun; 17(12):4052-62. PubMed ID: 21459799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
    Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
    Cunningham JM; Winham SJ; Wang C; Weiglt B; Fu Z; Armasu SM; McCauley BM; Brand AH; Chiew YE; Elishaev E; Gourley C; Kennedy CJ; Laslavic A; Lester J; Piskorz A; Sekowska M; Brenton JD; Churchman M; DeFazio A; Drapkin R; Elias KM; Huntsman DG; Karlan BY; Köbel M; Konner J; Lawrenson K; Papaemmanuil E; Bolton KL; Modugno F; Goode EL
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):132-141. PubMed ID: 34697060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
    Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
    Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.
    Lee PS; Teaberry VS; Bland AE; Huang Z; Whitaker RS; Baba T; Fujii S; Secord AA; Berchuck A; Murphy SK
    Int J Cancer; 2010 Mar; 126(6):1378-89. PubMed ID: 19642140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
    Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers.
    Losi L; Fonda S; Saponaro S; Chelbi ST; Lancellotti C; Gozzi G; Alberti L; Fabbiani L; Botticelli L; Benhattar J
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].
    Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor WT1 and promoter CpG hypomethylation coactivate HOXA10 expression in ovarian cancer.
    Jiang Y; Chu Y; Tang W; Wan Y; Zhang L; Cheng W
    Curr Pharm Des; 2014; 20(11):1647-54. PubMed ID: 23888944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance.
    Sung HY; Han J; Chae YJ; Ju W; Lee Kang J; Park AK; Ahn JH
    BMB Rep; 2023 Jun; 56(6):347-352. PubMed ID: 37013346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.
    Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK
    Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.
    Li L; Zheng H; Huang Y; Huang C; Zhang S; Tian J; Li P; Sood AK; Zhang W; Chen K
    Carcinogenesis; 2017 Aug; 38(8):797-805. PubMed ID: 28637314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.
    Kolbe DL; DeLoia JA; Porter-Gill P; Strange M; Petrykowska HM; Guirguis A; Krivak TC; Brody LC; Elnitski L
    PLoS One; 2012; 7(3):e32941. PubMed ID: 22403726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
    Strathdee G; Vass JK; Oien KA; Siddiqui N; Curto-Garcia J; Brown R
    Gynecol Oncol; 2005 Jun; 97(3):898-903. PubMed ID: 15894365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the effect of DNA methylation on gene expression in cancer cells.
    Lee CJ; Evans J; Kim K; Chae H; Kim S
    Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.